Somatostatin (SST), a growth hormone inhibitory peptide, was found to play an important role in many CNS pathological conditions, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and demyelinating disease (21, 31, 32). This evidence concerns the gene GH1 and demyelinating disease.